ATE247474T1 - Verwendung von inosittriphosphat zur herstellung von arzneimitteln - Google Patents
Verwendung von inosittriphosphat zur herstellung von arzneimittelnInfo
- Publication number
- ATE247474T1 ATE247474T1 AT95942373T AT95942373T ATE247474T1 AT E247474 T1 ATE247474 T1 AT E247474T1 AT 95942373 T AT95942373 T AT 95942373T AT 95942373 T AT95942373 T AT 95942373T AT E247474 T1 ATE247474 T1 AT E247474T1
- Authority
- AT
- Austria
- Prior art keywords
- inosite
- triphosphate
- medicinal products
- producing medicinal
- producing
- Prior art date
Links
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
- 235000011178 triphosphate Nutrition 0.000 title 1
- 239000001226 triphosphate Substances 0.000 title 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 title 1
- MMWCIQZXVOZEGG-UHFFFAOYSA-N 1,4,5-IP3 Natural products OC1C(O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(O)C1OP(O)(O)=O MMWCIQZXVOZEGG-UHFFFAOYSA-N 0.000 abstract 2
- MMWCIQZXVOZEGG-XJTPDSDZSA-N D-myo-Inositol 1,4,5-trisphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O MMWCIQZXVOZEGG-XJTPDSDZSA-N 0.000 abstract 2
- 230000002001 anti-metastasis Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9404568A SE9404568L (sv) | 1994-12-30 | 1994-12-30 | Användning av inositoltrisfosfat för beredning av läkemedel |
| PCT/SE1995/001585 WO1996020715A1 (en) | 1994-12-30 | 1995-12-22 | The use of inositoltrisphosphate for the preparing of medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE247474T1 true ATE247474T1 (de) | 2003-09-15 |
Family
ID=20396521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95942373T ATE247474T1 (de) | 1994-12-30 | 1995-12-22 | Verwendung von inosittriphosphat zur herstellung von arzneimitteln |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0794786B1 (de) |
| JP (1) | JPH10511677A (de) |
| AT (1) | ATE247474T1 (de) |
| AU (1) | AU4361996A (de) |
| DE (1) | DE69531554T2 (de) |
| SE (1) | SE9404568L (de) |
| WO (1) | WO1996020715A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0215102A (pt) * | 2001-12-13 | 2004-11-03 | Vital Health Sciences Pty Ltd | Transporte transdermal de compostos, formulação tópica, método para melhorar a absorção da pele, método para a terapia de reposição hormonal, uso de um ou mais derivados de fosfato de um composto hidróxi farmacêutico em um sistema de aplicação transdermal, sistema de aplicação transdermal, método para aplicação de um composto hidróxi farmacêutico a um indivìduo e para melhorar a eficácia de uma formulação |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| MX2007015949A (es) | 2005-06-17 | 2008-03-07 | Vital Health Sciences Pty Ltd | Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos. |
| US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| JP5806287B2 (ja) | 2010-03-30 | 2015-11-10 | フォスファジェニクス リミティド | 経皮送達パッチ |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| MX383940B (es) | 2015-12-09 | 2025-03-14 | Phosphagenics Ltd | Formulación farmacéutica que contiene tocol fosfato. |
| JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3336583A1 (de) * | 1983-09-26 | 1985-04-25 | Udo Dr. 8400 Regensburg Ehrenfeld | Erzeugnis zur diagnose und therapie von malignen tumoren |
| US4952396A (en) * | 1986-11-19 | 1990-08-28 | Linus Pauling Institute Of Science & Medicine | Method of using phytic acid for inhibiting tumor growth |
-
1994
- 1994-12-30 SE SE9404568A patent/SE9404568L/ not_active Application Discontinuation
-
1995
- 1995-12-22 AT AT95942373T patent/ATE247474T1/de not_active IP Right Cessation
- 1995-12-22 WO PCT/SE1995/001585 patent/WO1996020715A1/en not_active Ceased
- 1995-12-22 DE DE69531554T patent/DE69531554T2/de not_active Expired - Fee Related
- 1995-12-22 JP JP8520899A patent/JPH10511677A/ja active Pending
- 1995-12-22 AU AU43619/96A patent/AU4361996A/en not_active Abandoned
- 1995-12-22 EP EP95942373A patent/EP0794786B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0794786B1 (de) | 2003-08-20 |
| DE69531554D1 (de) | 2003-09-25 |
| AU4361996A (en) | 1996-07-24 |
| SE9404568L (sv) | 1996-07-01 |
| WO1996020715A1 (en) | 1996-07-11 |
| JPH10511677A (ja) | 1998-11-10 |
| SE9404568D0 (sv) | 1994-12-30 |
| DE69531554T2 (de) | 2004-06-17 |
| EP0794786A1 (de) | 1997-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE116848T1 (de) | Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris. | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| DE3772429D1 (de) | Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten. | |
| ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| NO971568L (no) | Analoger av keratinocyttvekstfaktor | |
| DE69113386D1 (de) | Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern. | |
| ATE269077T1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
| DE69423179D1 (de) | Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten | |
| DE68924714D1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. | |
| ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
| DE3583220D1 (de) | Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten. | |
| DE59003144D1 (de) | Destillationsanlage zur Herstellung von Wasserstoff-Peroxid. | |
| ATE82127T1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
| ATE196738T1 (de) | Verwendung von immunglobulin-präparationen zur herstellung eines medikaments zur oralen verabreichung zur behandlung und prophylaxe chronischer schmerzzustände | |
| ATE107168T1 (de) | Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression. | |
| DE69531554D1 (de) | Verwendung von inosittriphosphat zur herstellung von arzneimitteln | |
| ATE79254T1 (de) | Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen. | |
| ATE240116T1 (de) | Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie | |
| DE69432124D1 (de) | Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| DE69610045D1 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| ATE139696T1 (de) | Verwendung von benzothiazepinen zur herstellung von arzneimitteln zur behandlung von epileptischen anfällen | |
| DE59805897D1 (de) | VERWENDUNG VON HUMANEM alpha 1-SAUREN GLYCOPROTEIN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN PRÄPARATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |